Daunorubicin hydrochloride and Constipation - a phase IV clinical study of FDA data

Summary:

Constipation is reported as a side effect among people who take Daunorubicin hydrochloride (daunorubicin hydrochloride), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Methotrexate, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Constipation when taking Daunorubicin hydrochloride. It is created by eHealthMe based on reports of 1,681 people who have side effects when taking Daunorubicin hydrochloride from the FDA, and is updated regularly.

What is Daunorubicin hydrochloride?

Daunorubicin hydrochloride has active ingredients of daunorubicin hydrochloride. eHealthMe is studying from 1,686 Daunorubicin hydrochloride users. Check the latest studies of Daunorubicin hydrochloride.

What is Constipation?

Constipation is found to be associated with 3,004 drugs and 4,619 conditions by eHealthMe. Check the latest studies of Constipation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

1,681 people reported to have side effects when taking Daunorubicin hydrochloride.
Among them, 11 people (0.65%) have Constipation.

Could Daunorubicin hydrochloride cause Constipation?

Among these 11 people:

How long have people been on Daunorubicin hydrochloride when they have Constipation? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Constipation when taking Daunorubicin hydrochloride? *

  • female: 62.5 %
  • male: 37.5 %

What is the age of people who have Constipation when taking Daunorubicin hydrochloride? *

  • 0-1: 0.0 %
  • 2-9: 44.44 %
  • 10-19: 22.22 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 11.11 %
  • 60+: 22.22 %

What are other drugs people take besides Daunorubicin hydrochloride? *

  1. Prednisone: 4 people, 36.36%
  2. Methotrexate: 4 people, 36.36%
  3. Amphotericin B: 3 people, 27.27%
  4. Cyclophosphamide: 3 people, 27.27%
  5. Oncaspar: 3 people, 27.27%
  6. Mercaptopurine: 2 people, 18.18%
  7. Etoposide: 2 people, 18.18%
  8. Paroxetine Hydrochloride: 2 people, 18.18%
  9. Dexamethasone Sodium Phosphate: 2 people, 18.18%
  10. Bactrim: 2 people, 18.18%

What are other side effects people have besides Constipation? *

  1. Stomatitis (inflammation of mucous membrane of mouth): 4 people, 36.36%
  2. Fever: 3 people, 27.27%
  3. Consciousness - Decreased: 3 people, 27.27%
  4. Areflexia (absence of a reflex): 3 people, 27.27%
  5. Abdominal Pain: 2 people, 18.18%
  6. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 18.18%
  7. Heart Rate Increased: 2 people, 18.18%
  8. Hypotension (abnormally low blood pressure): 2 people, 18.18%
  9. Leukoencephalopathy (disease of the white matter in the brain): 2 people, 18.18%
  10. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 18.18%

What are the existing conditions these people have? *

  1. B-Cell Type Acute Leukaemia (cancer of the white blood cells): 2 people, 18.18%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 18.18%
  3. Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 9.09%
  4. Burkitt's Lymphoma (cancer of the lymphatic system): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Daunorubicin hydrochloride and have Constipation?

- Check whether Constipation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daunorubicin hydrochloride:

Constipation treatments and more:

How severe was Constipation and when was it recovered:

Expand to all the drugs that have ingredients of daunorubicin hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Daunorubicin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Constipation:

Browse all the conditions that are associated with Constipation:


How the study uses the data?

The study uses data from the FDA. It is based on daunorubicin hydrochloride (the active ingredients of Daunorubicin hydrochloride) and Daunorubicin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: